We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+6.68%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$3.45B
AUM Growth
+$422M
(+14%)
Cap. Flow
+$284M
Cap. Flow
% of AUM
8.23%
Top 10 Holdings %
Top 10 Hldgs %
9.84%
Holding
604
New
94
Increased
204
Reduced
207
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Rentals
URI
|
+$30.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$30M |
| 3 |
DexCom
DXCM
|
+$29.1M |
| 4 |
AGN
Allergan plc
AGN
|
+$28.8M |
| 5 |
Mettler-Toledo International
MTD
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$27.9M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$25.3M |
| 3 |
Ferrari
RACE
|
+$23.6M |
| 4 |
Allegion
ALLE
|
+$22.4M |
| 5 |
Mercado Libre
MELI
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.96% |
| 2 | Technology | 18.8% |
| 3 | Consumer Discretionary | 14.63% |
| 4 | Industrials | 11.4% |
| 5 | Financials | 11.18% |
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
WAS
SGI
AAM
PDT Partners's Q4 2017 Portfolio in Review
As of Q4 2017, PDT Partners held 604 positions worth $3.45B, up 14% from $3.02B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
PDT Partners deployed $284M of net new capital in Q4 2017, opening 94 new positions and adding to 204 existing holdings. Its largest new stake was United Rentals: 201,900 shares worth $34.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $25.3M trimmed.
- PDT Partners's largest Q4 2017 buy was United Rentals: 201,900 shares worth $34.7M.
- PDT Partners added most to Celgene Corp in Q4 2017, an estimated $13.7M increase.
- PDT Partners's biggest Q4 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $25.3M.
- PDT Partners fully exited Alnylam Pharmaceuticals in Q4 2017, selling an estimated $27.9M.
- PDT Partners's ten largest holdings make up 9.8% of its $3.45B portfolio in Q4 2017.
- PDT Partners opened 94 new positions and closed 76 in Q4 2017.
- PDT Partners's portfolio value rose 14% quarter-over-quarter to $3.45B.
Based on PDT Partners's 13F filing for Q4 2017, filed 14 Feb 2018.